Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kolitz

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Blood|February 26, 2000
Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responsesJ Pinilla-Ibarz, K Cathcart, T Korontsvit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumorsD R Budman, L N Igwemezie, S Kaul, et al.
Blood|February 1, 1997
Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022J O Moore, R K Dodge, P C Amrein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1997
Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemiaD Serrano, J Monteiro, S L Allen, et al.
American Journal of Clinical Oncology|July 28, 2001
Treatment of aggressive non-Hodgkin's lymphoma in elderly patients with thiotepa, Novantrone (mitoxantrone), vincristine, prednisone (TNOP)S M Lichtman, J Kolitz, D R Budman, et al.
Cancer Chemotherapy and Pharmacology|July 19, 2001
Phase I and pharmacokinetic study of LY309887: a specific inhibitor of purine biosynthesisD R Budman, R Johnson, B Barile, et al.
The New England Journal of Medicine|December 15, 2000
Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemiaK R Rai, B L Peterson, F R Appelbaum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphomaA Tulpule, M U Rarick, J Kolitz, et al.
Blood|September 9, 1999
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemiaR N Damle, T Wasil, F Fais, et al.
The Journal of Clinical Investigation|October 1, 1996
Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cellsF Fais, B Sellars, F Ghiotto, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Blood|February 26, 2000
Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responsesJ Pinilla-Ibarz, K Cathcart, T Korontsvit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumorsD R Budman, L N Igwemezie, S Kaul, et al.
Blood|February 1, 1997
Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022J O Moore, R K Dodge, P C Amrein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1997
Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemiaD Serrano, J Monteiro, S L Allen, et al.
American Journal of Clinical Oncology|July 28, 2001
Treatment of aggressive non-Hodgkin's lymphoma in elderly patients with thiotepa, Novantrone (mitoxantrone), vincristine, prednisone (TNOP)S M Lichtman, J Kolitz, D R Budman, et al.
Cancer Chemotherapy and Pharmacology|July 19, 2001
Phase I and pharmacokinetic study of LY309887: a specific inhibitor of purine biosynthesisD R Budman, R Johnson, B Barile, et al.
The New England Journal of Medicine|December 15, 2000
Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemiaK R Rai, B L Peterson, F R Appelbaum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphomaA Tulpule, M U Rarick, J Kolitz, et al.
Blood|September 9, 1999
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemiaR N Damle, T Wasil, F Fais, et al.
The Journal of Clinical Investigation|October 1, 1996
Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cellsF Fais, B Sellars, F Ghiotto, et al.
Pageof 2